Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Enlivex Ltd. before investing.

In this article, we go over a few key elements for understanding Enlivex Ltd.’s stock price such as:

• Enlivex Ltd.’s current stock price and volume
• Why Enlivex Ltd.’s stock price changed recently
• Upgrades and downgrades for ENLV from analysts
• ENLV’s stock price momentum as measured by its relative strength

About Enlivex Ltd. (ENLV)

Before we jump into Enlivex Ltd.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.

Want to learn more about Enlivex Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Enlivex Ltd..

Enlivex Ltd.’s Stock Price as of Market Close

As of April 21, 2026, 10:47 AM, CST, Enlivex Ltd.’s stock price was $0.904.

Enlivex Ltd. is up 3.24% from its previous closing price of $0.876.

During the last market session, Enlivex Ltd.’s stock traded between $0.862 and $0.980. Currently, there are approximately 111.09 million shares outstanding for Enlivex Ltd..

Enlivex Ltd.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Enlivex Ltd. Stock Price History

Enlivex Ltd.’s (ENLV) price is currently down 2.77% so far this month.

During the month of April, Enlivex Ltd.’s stock price has reached a high of $1.060 and a low of $0.741.

Over the last year, Enlivex Ltd. has hit prices as high as $2.100 and as low as $0.660. Year to date, Enlivex Ltd.’s stock is up 28.6%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Enlivex Ltd. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 20, 2026, there were 0 analysts who downgraded Enlivex Ltd.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Enlivex Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Enlivex Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Enlivex Ltd. (ENLV) by visiting AAII Stock Evaluator.

Relative Price Strength of Enlivex Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 20, 2026, Enlivex Ltd. has a weighted four-quarter relative price strength of -7.68%, which translates to a Momentum Score of 29 and is considered to be Weak.

Want to learn more about how Enlivex Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Enlivex Ltd. Stock Price: Bottom Line

As of April 21, 2026, Enlivex Ltd.’s stock price is $0.904, which is up 3.24% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Enlivex Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.